PROGRAMME
The event programme is shown below. Approximately 20-25% of the lectures will be presented in the conference room as online talks, in order to enable the participation of renowned speakers who otherwise would not be able to travel to Rio to give a talk. Remote lectures are marked with * on the programme below.
Workshops
From Monday to Thursday, from 15h15 to 17h00, several workshops will take place in parallel, allowing participants to choose among the several topics offered each day. These Workshops will promote a greater interaction among participants by dividing them into small groups to discuss and propose solutions to case studies and technical problems proposed by the speakers.
Monday, December 1st:
- Bioprinting for next-gen cell culture (Leandra Baptista, UFRJ and Gcell, Brazil)
- Plasmid DNA: A critical and fundamental resource for innovative medical therapies (Gabriela Esteves and Maira Pellegrini, Biomanguinhos/Fiocruz, Brazil)
- Organoids: cutting-edge models for preclinical studies in biologic product development (Mariela Bollati, Pasteur Institute of Montevideo, Uruguay)
Tuesday, December 2nd:
- Vaccine adjuvant formulations: from bench to clinic (Christopher Fox*, Utah State University, USA, *remote participation of speaker)
- Advanced-therapy medicinal products (ATMPs): where are we and challenges to enable a larger access (Daniel Ribeiro and Leonardo Batista Silva, Biomanguinhos/Fiocruz, Brazil)
- Design and execution of first-in-human clinical trials (Helton Santiago, UFMG, Brazil)
Wednesday, December 3rd:
- Designing living biomaterials as tissue engineering cellularized platforms (Angela Moraes, Unicamp, Brazil)
- Manufacturing the future: CRISPR-based advanced therapies (Bruno Solano, ID’Or, Brazil)
- Generation of stable cell clones using high-speed cell sorting (Mariela Bollati, Pasteur Institute of Montevideo, Uruguay)
- Technology transfer: a tool to implement new technologies (Rodrigo Coelho, Biomanguinhos/Fiocruz, Brazil)
Thursday, December 4th:
- Monitoring cell respiration rate (Aldo Tonso, USP, Brazil)
- A case study on the conformational stability of SARS-CoV-2 glycoprotein variants (Guilherme Oliveira, UFRJ, Brazil)
- Economic and sustainability aspects in the manufacture of biopharmaceutical products (Rui Castro, UFRJ, Brazil)
SPONSORS
